$BMY Recent Headlines Bristol-Myers gets posit
Post# of 44884
Posted On: 07/02/2014 11:36:29 AM
$BMY Recent Headlines
Bristol-Myers gets positive Hep C opinion from EMA committee 7:11 a.m. June 27, 2014 - Ciara Linnane
Bristol-Myers gets positive Hep C opinion from EMA committee 7:05 a.m. June 27, 2014 - Ciara Linnane
Stakes rising for Shire as AbbVie makes its case for buying the drug maker 12:15 p.m. June 25, 2014 - blogs.marketwatch.com
Robo-advisors, Syrian strikes and the stock-market shift they signal 6:45 a.m. June 25, 2014 - blogs.marketwatch.com
Bristol-Myers shares rise on melanoma drug study 7:13 p.m. June 24, 2014 - Wallace Witkowski
Newscast: Wall Street takes a spill after late dip 6:30 p.m. June 24, 2014 - MarketWatch
Bristol-Myers shares up 2% on melanoma drug study 4:57 p.m. June 24, 2014 - Wallace Witkowski
Will Allergan buy to thwart Valeant? 11:41 a.m. June 24, 2014 - blogs.marketwatch.com
AbbVie fails to woo Shire, but investors think someone can do it 11:10 a.m. June 20, 2014 - blogs.marketwatch.com
Coach slides on downgrade; FuelCell slumps on results 3:43 p.m. June 4, 2014 - Saumya Vaishampayan
Rising health-care costs are enough to make you sick 6:00 a.m. May 29, 2014 - Al Lewis
Cisco jumps on profit beat; Plug Power gains on upgrade 3:34 p.m. May 15, 2014 - Saumya Vaishampayan
Pfizer’s AstraZeneca bid is a ‘deal from hell’ 10:17 a.m. May 15, 2014 - Howard Gold
Bristol-Myers slides 4.7%, worst S&P 500 loser 9:33 a.m. May 15, 2014 - Sue Chang
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - blogs.marketwatch.com
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:30 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Roche's Deal Should Sound Early Warning 9:12 a.m. Today - The Wall Street Journal Interactive Edition
UPDATE: Barclays Downgrades Bristol-Myers, Cuts Price Target By 41% 9:06 a.m. Today - benzinga.com
Portola: A Small Biotech Stock That Could Double - And Then Double Again 8:40 a.m. Today - Seeking Alpha
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More 8:01 a.m. Today - 247WallSt.com
Benzinga's Top Downgrades 7:01 a.m. Today - benzinga.com
Isis - Addressing Some Of The Bull Arguments To My Short Thesis 12:09 p.m. July 1, 2014 - Seeking Alpha
Beware The Hand Of Government 10:02 a.m. June 28, 2014 - Seeking Alpha
The World's Most Respected Companies 4:52 a.m. June 28, 2014 - Barrons.com
Bristol-Myers Squibb: Expect Accelerated Dividend Growth In The Near Term 11:27 a.m. June 27, 2014 - Seeking Alpha
Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods 10:50 a.m. June 27, 2014 - Investors Business Daily
Pfizer, Bristol-Myers Squibb Announce Positive Opinion For Treatments 8:36 a.m. June 27, 2014 - benzinga.com
Bristol-Myers Gets Positive CHMP Opinions 7:51 a.m. June 27, 2014 - The Wall Street Journal Interactive Edition
CHMP recommends label expansion for Eliquis 7:44 a.m. June 27, 2014 - Seeking Alpha
CHMP recommends EMA approval for Daklinza 7:30 a.m. June 27, 2014 - Seeking Alpha
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza for Treatment of Chronic Hepatitis C in the European Union 6:01 a.m. June 27, 2014 - benzinga.com
3 Stocks Dragging The Health Care Sector Downward 1:03 p.m. June 26, 2014 - TheStreet.com
5 of the Best New Stocks of Q2 2014 3:30 a.m. June 26, 2014 - InvestorPlace.com
Why Bristol-Myers Squibb (BMY) Stock Is Climbing Today 12:21 p.m. June 25, 2014 - TheStreet.com
Bristol-Myers Stock Up On Nivolumab Trial Success 10:11 a.m. June 25, 2014 - Investors Business Daily
Hottest Healthcare Stocks Now – BMY ABBV SHPG LGND 8:30 a.m. June 25, 2014 - InvestorPlace.com
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. Today - BusinessWire - BZX
Bristol-Myers Squibb Company - Product Pipeline Review - 2014 1:51 p.m. July 1, 2014 - PR Newswire - PRF
Bristol-Myers Squibb to Announce Results for Second Quarter on July 24 10:11 a.m. July 1, 2014 - BusinessWire - BZX
The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022 11:30 a.m. June 30, 2014 - PR Newswire - PRF
Collaborations, Critical Takeover Decisions, Quarterly Dividends, and Litigation Settlements - Analyst Notes on Bristol-Myers, Allergan, Bard, Perrigo and Health Net 7:50 a.m. June 30, 2014 - PR Newswire - PRF
Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:00 a.m. June 27, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza® (daclatasvir) for Treatment of Chronic Hepatitis C in the European Union 7:00 a.m. June 27, 2014 - BusinessWire - BZX
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before 9:37 a.m. June 26, 2014 - ACCESSWIRE
Humana Hires Experienced Business/Government Executive To Lead Company’s Washington D.C.-based Federal Affairs 1:00 p.m. June 25, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Expands Access to Clinical Trial Data Through Collaboration with Academic Research Institute 8:01 a.m. June 24, 2014 - BusinessWire - BZX
Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments 12:00 p.m. June 19, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Announces Dividend 4:30 p.m. June 17, 2014 - BusinessWire - BZX
Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors 8:01 a.m. June 17, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Selects NGA Human Resources to Provide Payroll and Workforce Administration Services to North America Employees 8:00 a.m. June 17, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry -- Research on AbbVie, AcelRx Pharma, Bristol-Myers Squibb, and GW Pharma 7:10 a.m. June 13, 2014 - PR Newswire - PRF
U.S. Court of Appeals Denies Appeal in Baraclude Patent Case 3:41 p.m. June 12, 2014 - BusinessWire - BZX
Teva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent 3:32 p.m. June 12, 2014 - BusinessWire - BZX
OptiNose Expands Senior Management Team with Three Key Appointments in Core Business Areas of Operations, Regulatory Affairs and Commercialization 8:30 a.m. June 12, 2014 - PR Newswire - PRF
Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer 8:23 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
Bristol-Myers gets positive Hep C opinion from EMA committee 7:11 a.m. June 27, 2014 - Ciara Linnane
Bristol-Myers gets positive Hep C opinion from EMA committee 7:05 a.m. June 27, 2014 - Ciara Linnane
Stakes rising for Shire as AbbVie makes its case for buying the drug maker 12:15 p.m. June 25, 2014 - blogs.marketwatch.com
Robo-advisors, Syrian strikes and the stock-market shift they signal 6:45 a.m. June 25, 2014 - blogs.marketwatch.com
Bristol-Myers shares rise on melanoma drug study 7:13 p.m. June 24, 2014 - Wallace Witkowski
Newscast: Wall Street takes a spill after late dip 6:30 p.m. June 24, 2014 - MarketWatch
Bristol-Myers shares up 2% on melanoma drug study 4:57 p.m. June 24, 2014 - Wallace Witkowski
Will Allergan buy to thwart Valeant? 11:41 a.m. June 24, 2014 - blogs.marketwatch.com
AbbVie fails to woo Shire, but investors think someone can do it 11:10 a.m. June 20, 2014 - blogs.marketwatch.com
Coach slides on downgrade; FuelCell slumps on results 3:43 p.m. June 4, 2014 - Saumya Vaishampayan
Rising health-care costs are enough to make you sick 6:00 a.m. May 29, 2014 - Al Lewis
Cisco jumps on profit beat; Plug Power gains on upgrade 3:34 p.m. May 15, 2014 - Saumya Vaishampayan
Pfizer’s AstraZeneca bid is a ‘deal from hell’ 10:17 a.m. May 15, 2014 - Howard Gold
Bristol-Myers slides 4.7%, worst S&P 500 loser 9:33 a.m. May 15, 2014 - Sue Chang
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - blogs.marketwatch.com
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:30 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Roche's Deal Should Sound Early Warning 9:12 a.m. Today - The Wall Street Journal Interactive Edition
UPDATE: Barclays Downgrades Bristol-Myers, Cuts Price Target By 41% 9:06 a.m. Today - benzinga.com
Portola: A Small Biotech Stock That Could Double - And Then Double Again 8:40 a.m. Today - Seeking Alpha
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More 8:01 a.m. Today - 247WallSt.com
Benzinga's Top Downgrades 7:01 a.m. Today - benzinga.com
Isis - Addressing Some Of The Bull Arguments To My Short Thesis 12:09 p.m. July 1, 2014 - Seeking Alpha
Beware The Hand Of Government 10:02 a.m. June 28, 2014 - Seeking Alpha
The World's Most Respected Companies 4:52 a.m. June 28, 2014 - Barrons.com
Bristol-Myers Squibb: Expect Accelerated Dividend Growth In The Near Term 11:27 a.m. June 27, 2014 - Seeking Alpha
Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods 10:50 a.m. June 27, 2014 - Investors Business Daily
Pfizer, Bristol-Myers Squibb Announce Positive Opinion For Treatments 8:36 a.m. June 27, 2014 - benzinga.com
Bristol-Myers Gets Positive CHMP Opinions 7:51 a.m. June 27, 2014 - The Wall Street Journal Interactive Edition
CHMP recommends label expansion for Eliquis 7:44 a.m. June 27, 2014 - Seeking Alpha
CHMP recommends EMA approval for Daklinza 7:30 a.m. June 27, 2014 - Seeking Alpha
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza for Treatment of Chronic Hepatitis C in the European Union 6:01 a.m. June 27, 2014 - benzinga.com
3 Stocks Dragging The Health Care Sector Downward 1:03 p.m. June 26, 2014 - TheStreet.com
5 of the Best New Stocks of Q2 2014 3:30 a.m. June 26, 2014 - InvestorPlace.com
Why Bristol-Myers Squibb (BMY) Stock Is Climbing Today 12:21 p.m. June 25, 2014 - TheStreet.com
Bristol-Myers Stock Up On Nivolumab Trial Success 10:11 a.m. June 25, 2014 - Investors Business Daily
Hottest Healthcare Stocks Now – BMY ABBV SHPG LGND 8:30 a.m. June 25, 2014 - InvestorPlace.com
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. Today - BusinessWire - BZX
Bristol-Myers Squibb Company - Product Pipeline Review - 2014 1:51 p.m. July 1, 2014 - PR Newswire - PRF
Bristol-Myers Squibb to Announce Results for Second Quarter on July 24 10:11 a.m. July 1, 2014 - BusinessWire - BZX
The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022 11:30 a.m. June 30, 2014 - PR Newswire - PRF
Collaborations, Critical Takeover Decisions, Quarterly Dividends, and Litigation Settlements - Analyst Notes on Bristol-Myers, Allergan, Bard, Perrigo and Health Net 7:50 a.m. June 30, 2014 - PR Newswire - PRF
Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:00 a.m. June 27, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza® (daclatasvir) for Treatment of Chronic Hepatitis C in the European Union 7:00 a.m. June 27, 2014 - BusinessWire - BZX
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before 9:37 a.m. June 26, 2014 - ACCESSWIRE
Humana Hires Experienced Business/Government Executive To Lead Company’s Washington D.C.-based Federal Affairs 1:00 p.m. June 25, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Expands Access to Clinical Trial Data Through Collaboration with Academic Research Institute 8:01 a.m. June 24, 2014 - BusinessWire - BZX
Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments 12:00 p.m. June 19, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Announces Dividend 4:30 p.m. June 17, 2014 - BusinessWire - BZX
Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors 8:01 a.m. June 17, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Selects NGA Human Resources to Provide Payroll and Workforce Administration Services to North America Employees 8:00 a.m. June 17, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry -- Research on AbbVie, AcelRx Pharma, Bristol-Myers Squibb, and GW Pharma 7:10 a.m. June 13, 2014 - PR Newswire - PRF
U.S. Court of Appeals Denies Appeal in Baraclude Patent Case 3:41 p.m. June 12, 2014 - BusinessWire - BZX
Teva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent 3:32 p.m. June 12, 2014 - BusinessWire - BZX
OptiNose Expands Senior Management Team with Three Key Appointments in Core Business Areas of Operations, Regulatory Affairs and Commercialization 8:30 a.m. June 12, 2014 - PR Newswire - PRF
Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer 8:23 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼